Breaking News Instant updates and real-time market news.

PCRX

Pacira

$48.65

1.25 (2.64%)

06:23
03/21/17
03/21
06:23
03/21/17
06:23

Pacira price target raised to $59 from $54 at Barclays

Barclays analyst Douglas Tsao raised his price target for Pacira Pharmaceuticals to $59 saying he left last week's American Academy of Orthopaedic Surgeons conference with increased confidence that the company's Exparel will sustain its recent commercial momentum. The analyst expects the pain treatment's sales will double in the coming years. He keeps an Overweight rating on Pacira.

PCRX Pacira
$48.65

1.25 (2.64%)

03/14/17
PIPR
03/14/17
NO CHANGE
Target $60
PIPR
Overweight
Piper more confident in Pacira after surgeon survey
Piper Jaffray analyst David Amsellem says his firm's survey of 29 orthopedic surgeons reinforces his confidence that Pacira Pharmaceuticals will be able to drive sustainable long-term volume growth for Exparel. Out of the 29 respondents, 83% noted that the data from the total knee arthroplasty study would result in them viewing Exparel's efficacy profile at least slightly more favorably, Amsellem tells investors in a research note. He believes Pacira is trading at an attractive risk/reward profile and reiterates an Overweight rating on the name with a $60 price target.
03/02/17
03/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kite Pharma (KITE) downgraded to Neutral from Buy at Citi with analyst Robyn Karnauskas saying this week's rally on the "strong data" price a lot of value into the shares. The analyst expects approval of axicabtagene and estimates worldwide peak sales of $1.7B, but sees little share upside from the pipeline in the near-term. She raised her price target for Kite shares to $87 from $62. 2. Apache (APA) downgraded to Underweight from Equal Weight at Barclays with analyst Thomas Driscoll saying he expects the company's 2018 oil volumes to fall below 2016 levels. He cut his price target for the shares to $50 from $56. 3. American Eagle (AEO) downgraded to Neutral from Buy at BofA/Merrill with analyst Stephen Albert citing disappointing first quarter comparable-store sales guidance. 4. TripAdvisor (TRIP) downgraded to Neutral from Overweight at Piper Jaffray with analyst Michael Olson saying estimates may move lower as the company potentially increases investment in re-education. Olson thinks TripAdvisor shares may be range-bound through the remainder of the year and he lowered his price target for the stock to $47 from $60. 5. Pacira (PCRX) downgraded to Sell from Neutral at Janney Capital with analyst Ken Trbovich stating that its guidance suggests no meaningful change in the outlook for Exparel sales this year. While the company also announced positive results from its Phase 4 study of Exparel in total knee replacement surgery, it may take "years" for the company to fully exploit this commercially, said Trbovich, who raised his fair value estimate on the stock to $38 from $34. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/02/17
JANY
03/02/17
DOWNGRADE
Target $38
JANY
Sell
Pacira downgraded to Sell from Neutral at Janney Capital
Janney Capital analyst Ken Trbovich downgraded Pacira to Sell from Neutral, statin that its guidance suggests no meaningful change in the outlook for Exparel sales this year. While the company also announced positive results from its Phase 4 study of Exparel in total knee replacement surgery, it may take "years" for the company to fully exploit this commercially, said Trbovich, who raised his fair value estimate on the stock to $38 from $34.
03/02/17
JEFF
03/02/17
NO CHANGE
Target $60
JEFF
Buy
Pacira price target raised to $60 from $53 at Jefferies
Jefferies analyst David Steinberg raised his price target for Pacira Pharmaceuticals to $60 saying the "much anticipated" and positive total knee arthroplasty study readout should "help considerably" with hospital payers. Pacira "looks to be playing offense in 2017," the analyst writes. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

EEI

Ecology & Environment

$9.90

-0.1 (-1.00%)

18:19
03/27/17
03/27
18:19
03/27/17
18:19
Hot Stocks
Ecology & Environment board urges shareholders to vote for company's nominees »

Ecology and Environment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDLI

PDL BioPharma

$2.05

0.07 (3.54%)

18:16
03/27/17
03/27
18:16
03/27/17
18:16
Hot Stocks
PDL BioPharma CFO discloses purchase of 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:15
03/27/17
03/27
18:15
03/27/17
18:15
General news
Breaking General news story  »

Dallas Federal Reserve…

RAVN

Raven

$29.75

0.45 (1.54%)

18:14
03/27/17
03/27
18:14
03/27/17
18:14
Hot Stocks
Raven CEO says 'entering fiscal year 2018 from a position of strength' »

"We are very pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

RAVN

Raven

$29.75

0.45 (1.54%)

18:12
03/27/17
03/27
18:12
03/27/17
18:12
Hot Stocks
Breaking Hot Stocks news story on Raven »

Raven sees FY18 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

RAVN

Raven

$29.75

0.45 (1.54%)

18:11
03/27/17
03/27
18:11
03/27/17
18:11
Earnings
Raven reports Q4 EPS 12c, consensus 15c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

OREX

Orexigen

$4.13

0.15 (3.77%)

18:05
03/27/17
03/27
18:05
03/27/17
18:05
Hot Stocks
Orexigen, Bruno reach distribution agreement for Mysimba »

Orexigen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

HUN

Huntsman

$22.89

0.24 (1.06%)

18:01
03/27/17
03/27
18:01
03/27/17
18:01
Hot Stocks
Huntsman moves up after projecting Q1 adjusted EBITDA to rise YoY »

Shares of chemical maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

PFE

Pfizer

$34.18

0.18 (0.53%)

, BMY

Bristol-Myers

$56.04

0.15 (0.27%)

18:00
03/27/17
03/27
18:00
03/27/17
18:00
Hot Stocks
Credit Suisse analysis shows value in hypothetical Pfizer-Bristol merger »

Credit Suisse analysts…

PFE

Pfizer

$34.18

0.18 (0.53%)

BMY

Bristol-Myers

$56.04

0.15 (0.27%)

NVS

Novartis

$75.10

0.73 (0.98%)

GILD

Gilead

$67.50

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

  • 01

    Apr

  • 27

    Apr

  • 02

    May

  • 02

    May

  • 06

    Jun

  • 26

    Jun

  • 27

    Aug

VRX

Valeant

$10.81

0.06 (0.56%)

18:00
03/27/17
03/27
18:00
03/27/17
18:00
Periodicals
Ex-Valeant CEO Pearson sues company over unpaid compensation, WSJ says »

Former Valeant CEO Mike…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 24

    Aug

DGLY

Digital Ally

$4.60

0.49 (11.92%)

, TASR

Taser

$22.47

-0.03 (-0.13%)

17:54
03/27/17
03/27
17:54
03/27/17
17:54
Earnings
Digital Ally reports Q4 adjusted EPS (63c), two estimates (20c) »

Reports Q4 revenue…

DGLY

Digital Ally

$4.60

0.49 (11.92%)

TASR

Taser

$22.47

-0.03 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

AEM

Agnico Eagle

$44.64

0.81 (1.85%)

17:51
03/27/17
03/27
17:51
03/27/17
17:51
Syndicate
Agnico Eagle to sell approximately 5M shares to institutional investor »

Agnico Eagle Mines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

  • 28

    Apr

HUN

Huntsman

$22.89

0.24 (1.06%)

17:50
03/27/17
03/27
17:50
03/27/17
17:50
Hot Stocks
Huntsman sees Q1 adjusted EBITDA to exceed the $274M reported in 1Q16 »

Huntsman Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

SELB

Selecta Biosciences

$11.92

-0.12 (-1.00%)

, RHT

Red Hat

$82.20

-0.76 (-0.92%)

17:43
03/27/17
03/27
17:43
03/27/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SELB

Selecta Biosciences

$11.92

-0.12 (-1.00%)

RHT

Red Hat

$82.20

-0.76 (-0.92%)

SNX

SYNNEX

$118.32

1.38 (1.18%)

PSIX

Power Solutions

$6.40

0.07 (1.11%)

OCN

Ocwen

$4.89

0.08 (1.66%)

TSRO

Tesaro

$156.73

-3.27 (-2.04%)

DRI

Darden

$75.58

-1.13 (-1.47%)

FMSA

Fairmount Santrol

$6.74

-0.08 (-1.17%)

HCLP

Hi-Crush Partners

$15.40

0.05 (0.33%)

DECK

Deckers Brands

$56.51

0.23 (0.41%)

CYRX

Cryoport

$3.75

0.2219 (6.29%)

EVH

Evolent Health

$21.25

0.4 (1.92%)

STOR

STORE Capital

$23.46

-0.25 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 28

    Mar

  • 04

    Apr

  • 06

    Apr

  • 12

    Apr

  • 02

    May

  • 03

    May

  • 09

    May

  • 30

    Jun

ADHD

Alcobra

17:41
03/27/17
03/27
17:41
03/27/17
17:41
Hot Stocks
Brosh raises stake in Alcobra to 10.9% ahead of investor meeting »

Brosh Capital disclosed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

PSIX

Power Solutions

$6.40

0.07 (1.11%)

17:33
03/27/17
03/27
17:33
03/27/17
17:33
Hot Stocks
Weichai America to invest $60M in Power Solutions »

Power Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RADA

RADA Electronic

$1.15

-0.04 (-3.36%)

17:32
03/27/17
03/27
17:32
03/27/17
17:32
Syndicate
Breaking Syndicate news story on RADA Electronic »

RADA Electronic files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$17.15

0.34 (2.02%)

17:29
03/27/17
03/27
17:29
03/27/17
17:29
Syndicate
Breaking Syndicate news story on iShares Silver Trust »

iShares Silver Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAU

iShares Gold Trust

$12.08

0.07 (0.58%)

17:28
03/27/17
03/27
17:28
03/27/17
17:28
Syndicate
Breaking Syndicate news story on iShares Gold Trust »

iShares Gold Trust files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GABC

German American Bancorp

$44.33

-0.33 (-0.74%)

17:25
03/27/17
03/27
17:25
03/27/17
17:25
Hot Stocks
German American Bancorp announces 3-for-2 stock split »

German American Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAF

Staffing 360 Solutions

$0.95

0.2215 (30.34%)

17:18
03/27/17
03/27
17:18
03/27/17
17:18
Hot Stocks
Staffing 360 Solutions, board reject buy-out offer from Jackson Investment Group »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$15.40

-0.24 (-1.53%)

17:16
03/27/17
03/27
17:16
03/27/17
17:16
Hot Stocks
Breaking Hot Stocks news story on Canada Goose »

Adage Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$140.32

-0.02 (-0.01%)

, AAPL

Apple

$140.88

0.24 (0.17%)

17:14
03/27/17
03/27
17:14
03/27/17
17:14
Periodicals
Facebook hires Apple vet to lead Oculus hardware efforts, Bloomberg says »

Facebook (FB) has hired…

FB

Facebook

$140.32

-0.02 (-0.01%)

AAPL

Apple

$140.88

0.24 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

ISTR

Investar Holding

$22.15

0.1 (0.45%)

17:13
03/27/17
03/27
17:13
03/27/17
17:13
Hot Stocks
Breaking Hot Stocks news story on Investar Holding »

EJF Capital reports 6.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$23.21

0.27 (1.18%)

17:10
03/27/17
03/27
17:10
03/27/17
17:10
Hot Stocks
Breaking Hot Stocks news story on Urban Outfitters »

Harry S. Cherken, Jr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.